We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-14.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.12B
Cap. Flow %
-0.82%
Top 10 Hldgs %
21.65%
Holding
3,641
New
264
Increased
1,460
Reduced
1,409
Closed
415

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
UNH icon
UnitedHealth
UNH
+$463M
3
ORCL icon
Oracle
ORCL
+$392M
4
ELV icon
Elevance Health
ELV
+$387M
5
PEP icon
PepsiCo
PEP
+$343M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$321M
2
BIDU icon
Baidu
BIDU
+$269M
3
NVDA icon
NVIDIA
NVDA
+$262M
4
ABBV icon
AbbVie
ABBV
+$260M
5
GM icon
General Motors
GM
+$248M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Healthcare 13.99%
3 Financials 12.35%
4 Consumer Discretionary 10.52%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNXP icon
3451
Tonix Pharmaceuticals
TNXP
$189M
-2
Closed -$315K
TOON icon
3452
Kartoon Studios
TOON
$34.8M
-108,412
Closed -$965K
TRDA icon
3453
Entrada Therapeutics
TRDA
$264M
-13,872
Closed -$130K
TSAT icon
3454
Telesat
TSAT
$891M
-31,999
Closed -$602K
TSHA icon
3455
Taysha Gene Therapies
TSHA
$1.86B
-105,426
Closed -$665K
TSLA icon
3456
CALL
Tesla
TSLA
$1.3T
-33,900
Closed -$10K
TSLA icon
3457
PUT
Tesla
TSLA
$1.3T
-54,300
Closed -$17K
TTWO icon
3458
PUT
Take-Two Interactive
TTWO
$45.2B
-29,900
Closed -$5K
TXMD icon
3459
TherapeuticsMD
TXMD
$24.3M
-21,234
Closed -$419K
UAVS icon
3460
AgEagle Aerial Systems
UAVS
$53.6M
-297
Closed -$332K
UL icon
3461
Unilever
UL
$136B
-12,348
Closed -$633K
ULTA icon
3462
PUT
Ulta Beauty
ULTA
$24.2B
-14,400
Closed -$6K
URGN icon
3463
UroGen Pharma
URGN
$2.31B
-94,660
Closed -$854K
UXIN
3464
Uxin Ltd
UXIN
$275M
-2,393
Closed -$244K
VATE icon
3465
INNOVATE Corp
VATE
$165M
-15,593
Closed -$592K
VHC icon
3466
VirnetX Holding Corp
VHC
$61.7M
-12,610
Closed -$479K
VKTX icon
3467
Viking Therapeutics
VKTX
$3.95B
-263,132
Closed -$855K
VOR icon
3468
Vor Biopharma
VOR
$1.3B
-2,765
Closed -$422K
VRA icon
3469
Vera Bradley
VRA
$97.8M
-106,512
Closed -$869K
VRCA icon
3470
Verrica Pharmaceuticals
VRCA
$88.3M
-3,279
Closed -$277K
VRM icon
3471
Vroom Inc
VRM
$49M
-4,874
Closed -$1.07M
VSTM icon
3472
Verastem
VSTM
$564M
-42,697
Closed -$651K
WFC icon
3473
CALL
Wells Fargo
WFC
$264B
-79,300
Closed -$4K
WMB icon
3474
CALL
Williams Companies
WMB
$86.2B
-27,000
Closed -$1K
WOLF icon
3475
CALL
Wolfspeed
WOLF
$1.69B
-30,900
Closed -$3K

Similar funds

Nuveen's Q2 2022 Portfolio in Review

As of Q2 2022, Nuveen held 3,641 positions worth $259B, down 16% from $309B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2022 filing shows 264 new, 1,460 increased, 1,409 reduced and 415 closed positions. Its largest new stake was Coinbase: 292,590 shares worth $13.8M. The largest sale was Cisco, an estimated $321M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2022 buy was Coinbase: 292,590 shares worth $13.8M.
  • Nuveen added most to Linde in Q2 2022, an estimated $499M increase.
  • Nuveen's biggest Q2 2022 reduction was Cisco, cutting an estimated $321M.
  • Nuveen fully exited Cerner Corp in Q2 2022, selling an estimated $135M.
  • Nuveen's ten largest holdings make up 22% of its $259B portfolio in Q2 2022.
  • Nuveen opened 264 new positions and closed 415 in Q2 2022.
  • Nuveen's portfolio value fell 16% quarter-over-quarter to $259B.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.